A global biopharmaceutical firm undergoing divestiture needed to migrate over 100TB of sensitive gene therapy and analytics data from its on-premises data center in Germany to a U.S.-based cloud solution. Facing challenges with legacy hardware, downtime, and limited expertise, the company partnered with Insight, which deployed AWS tools including Snowball for secure offline transfer, Control Tower for governance, and EC2, S3, and EFS for storage. The migration closed the costly data center, improved scalability, and streamlined compliance. The project delivered over 150% cost savings, enhanced performance, and positioned the firm for future high-performance compute needs.

Join for free to read